The health and economic benefits of the global programme to eliminate lymphatic filariasis (2000-2014).
<h4>Background</h4> <p>Lymphatic filariasis (LF), also known as elephantiasis, is a neglected tropical disease (NTD) targeted for elimination through a Global Programme to Eliminate LF (GPELF). Between 2000 and 2014, the GPELF has delivered 5.6 billion treatments to over 763 milli...
Main Authors: | Turner, H, Bettis, A, Chu, B, McFarland, D, Hooper, P, Ottesen, E, Bradley, M |
---|---|
Format: | Journal article |
Language: | English |
Published: |
BioMed Central
2016
|
Similar Items
-
Investment success in public health: An analysis of the cost-effectiveness and cost-benefit of the Global Programme to Eliminate Lymphatic Filariasis
by: Turner, H, et al.
Published: (2016) -
The health and economic burden of lymphatic filariasis prior to mass drug administration programmes
by: Mathew, C, et al.
Published: (2019) -
Economic evaluations of lymphatic filariasis interventions: A systematic review and research needs
by: Gedge, LM, et al.
Published: (2018) -
Evaluating the evidence for lymphatic filariasis elimination
by: Davis, E, et al.
Published: (2019) -
Elimination of lymphatic filariasis-Challenging but not impossible
by: Lakshmi Krishnasamy
Published: (2023-01-01)